(Q60148400)
Statements
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers (English)
Charles L Bennett
Jonathan R Nebeker
Paul R Yarnold
Cara C Tigue
David A Dorr
June M McKoy
Denys T Lau
Cara Angelotta
Sigmund A Weitzman
Benjamin Djulbegovic
Martin S Tallman
Timothy M Kuzel
Al B Benson
Steven M Trifilio
D Mark Courtney
Dennis W Raisch